Imaging Biometrics Ltd.
LSE:IBAI

Jigglypop Analysis For Imaging Biometrics Ltd. 🤓

Imaging Biometrics trades at 0.6244p after a 26.5% hit, sitting roughly 69% below its 52‑week high and 44% above the low. That spread (0.4333p–2.0p) and a price below both the 50‑day (0.8947p) and 200‑day (0.7896p) averages scream volatility, not value. The micro-cap’s decision to halt Phase II gallium maltolate shifts focus to commercial imaging software, with GE HealthCare distribution support, but near-term execution must now carry the story. While orphan and fast‑track designations preserve optionality, the equity case leans speculative until revenue traction and cash runway clarity offset binary R&D noise. Momentum is negative on one month and one day. Verdict: speculative rebound candidate, not a classic value play. Expect elevated swings while the strategy reset beds in through 2026.

About Imaging Biometrics Ltd. 👋

Imaging Biometrics Ltd., through its subsidiaries, delivers clinical services in medical imaging diagnostics across the United Kingdom, Switzerland, the European Union, and the United States. It operates through the Holding Company, Medical Software, and Oral Gallium Maltolate (GaM) divisions. The company develops ready-to-use healthcare software, including IB Clinic for all IB platforms; IB Neuro, an MR DSC perfusion analysis system; IB Delta Suite, which produces Delta T1 maps from routine MR scans; IB DCE and IB Diffusion, offering whole-body insights into blood flow and water diffusion; StoneChecker and Liver Surface Nodularity, CT processing tools that help clinicians non-invasively assess kidney stones and liver health; IB ASL to quantify cerebral blood flow for evaluating stroke, dementia, and other neurological disorders; IB Zero G, designed to eliminate the need for gadolinium contrast agents in standard imaging; and IB Nimble, which supports virtual collaboration among clinicians. It is also developing IB003, a gallium maltolate drug candidate in Phase 1 clinical trials for glioblastoma. Additionally, the company provides consulting services. The company was previously known as IQ-AI Limited and adopted the name Imaging Biometrics Ltd. in May 2025. Imaging Biometrics Ltd. was incorporated in 1965 and is headquartered in Saint Helier, Jersey.